Skip to search formSkip to main contentSkip to account menu

KPT-335

National Institutes of Health

Related topics

Related topics

1 relation

Broader (1)

verdinexor

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2014
2014
Abstract 3809: Evaluation of the novel, orally bioavailable selective inhibitor of nuclear export (SINE) KPT-335 (verdinexor) in spontaneous canine cancer: Results of phase I and phase II clinical…
Proceedings: AACR Annual Meeting 2014; April 5-9, 2014; San Diego, CA SINE (Selective Inhibitors of Nuclear Export) block the… 
2014
2014
Novel Therapeutics In Renal Disease Novel inhibitors of nuclear transport cause cell cycle arrest and decrease cyst growth in ADPKD associated with decreased CDK 4 levels
Matthew Tan, Hiromi I. Wettersten, Kristy Chu, David L. Huso, Terry Watnick, Sharon Friedlander, Yosef Landesman, and Robert H… 
2014
2014
Elizabeth In Vivo and In Vitro Replication Nuclear Export , Reduces Influenza A Virus Verdinexor , a Novel Selective Inhibitor of
Influenza is a global health concern, causing death, morbidity, and economic losses. Chemotherapeutics that target influenza… 
2013
2013
Evaluation Of The Novel, Orally Bioavailable Selective Inhibitor Of Nuclear Export (SINE) Verdinexor (KPT-335) In Spontaneous Canine Cancer: Results Of Phase I and Phase II Clinical Trials
SINE (Selective Inhibitors of Nuclear Export) block the activity of XPO1/CRM1, 1 of 7 nuclear export proteins in cells, forcing… 
2012
2012
Abstract LB-232: Preliminary results of a phase I study of the novel CRM1 inhibitors KPT-276 and KPT-335 in dogs with spontaneous cancer
Proceedings: AACR 103rd Annual Meeting 2012‐‐ Mar 31‐Apr 4, 2012; Chicago, IL Introduction: KPT-276 and KPT-335 are irreversible… 
By clicking accept or continuing to use the site, you agree to the terms outlined in our Privacy Policy (opens in a new tab), Terms of Service (opens in a new tab), and Dataset License (opens in a new tab)